GW-311616 is a highly potent, orally bioavailable, and long-acting inhibitor of human neutrophil elastase (HNE), with potential therapeutic applications in diseases involving excessive neutrophil elastase activity, such as inflammatory and respiratory disorders; it also demonstrates anti-leukemic effects by inhibiting proliferation and inducing apoptosis in leukemia cell lines (e.g., U937 and K562 cells) through modulation of Bax and Bcl-2 protein expression.